首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1975272

全球重组蛋白生产服务市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Recombinant Proteins Manufacturing Services Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 139 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

预计重组蛋白生产服务市场将从 2025 年的 66.1 亿美元成长到 2034 年的 294.3 亿美元，2026 年至 2034 年的复合年增长率为 18.05%。

由于对生物製药和先进治疗性蛋白质的需求不断增长，全球重组蛋白生产服务市场正在迅速扩张。製药和生物技术公司正将生产外包给专业的契约製造组织（CMO），以降低营运成本并提高效率。肿瘤学、免疫学和罕见疾病领域的研究进展也推动了对重组蛋白服务的需求。

关键成长要素包括临床试验数量的增加、生物相似药的扩张以及哺乳动物和微生物平台等表达系统的进步。对高品质、可扩展生产流程日益增长的需求正在推动对先进生产设施的投资。此外，监管机构对品质合规性的日益重视正在加强生物技术公司与服务供应商之间的合作。

随着全球生物製剂开发平臺的不断扩展，未来前景依然强劲。蛋白质工程和纯化製程的技术创新将进一步提高产量和成本效益。随着个人化医疗和标靶治疗的日益普及，重组蛋白生产服务预计将持续保持长期成长。

区域分析
北美市场分析、洞察与预测
- 我们
- 加拿大
- 墨西哥
欧洲市场分析、洞察与预测
- 英国
- 法国
- 德国
- 义大利
- 俄罗斯
- 其他欧洲国家
亚太市场分析、洞察与预测
- 印度
- 日本
- 韩国
- 澳洲
- 东南亚
- 亚太其他地区
拉丁美洲市场分析、洞察与预测
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 其他拉丁美洲国家
中东和非洲市场分析、洞察与预测
- 沙乌地阿拉伯
- UAE
- 以色列
- 南非
- 其他中东和非洲国家

第八章竞争情势

最新趋势
公司分类
供应链和销售管道合作伙伴（根据现有资讯）
市场占有率和市场定位分析（基于现有资讯）
供应商情况（基于现有资讯）
策略规划

第九章：公司简介

主要公司的市占率分析
公司简介
- Lonza Group AG
- Boehringer Ingelheim International GmbH
- FUJIFILM Diosynth Biotechnologies
- Merck KGaA
- Bruker Corporation（InVivo BioTech Services GmbH）
- Sino Biological Inc
- GenScript Biotech Corporation
- Kaneka Corporation（Kaneka Eurogentec SA）
- Polyplus Transfection（Xpress Biologics）
- Boster Biological Technology
- Trenzyme GmbH

简介目录

Product Code: VMR112112237

The Recombinant Proteins Manufacturing Services Market size is expected to reach USD 29.43 Billion in 2034 from USD 6.61 Billion (2025) growing at a CAGR of 18.05% during 2026-2034.

The Global Recombinant Proteins Manufacturing Services Market is expanding rapidly due to increasing demand for biologics and advanced therapeutic proteins. Pharmaceutical and biotechnology companies are outsourcing production to specialized contract manufacturing organizations to reduce operational costs and enhance efficiency. Growing research in oncology, immunology, and rare diseases is fueling demand for recombinant protein services.

Key growth drivers include rising clinical trials, expansion of biosimilars, and advancements in expression systems such as mammalian and microbial platforms. The push for high-quality and scalable production processes is encouraging investments in state-of-the-art manufacturing facilities. Additionally, regulatory emphasis on quality compliance is strengthening partnerships between biotech firms and service providers.

Future prospects remain strong as the biologics pipeline continues to expand globally. Technological innovation in protein engineering and purification processes will further improve yield and cost-effectiveness. As personalized medicine and targeted therapies gain traction, recombinant protein manufacturing services are poised for sustained long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service Type

Pre-clinical & Clinical Services
Commercial Production Services

By Host Cell

Mammalian Cells
Bacterial Cells
Insect Cells
Yeast & Fungi
Others

By End-User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes

COMPANIES PROFILED

Lonza Group AG, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Merck KGaA, Bruker Corporation InVivo BioTech Services GmbH, Sino Biological Inc, GenScript Biotech Corporation, Kaneka Corporation Kaneka Eurogentec SA, Polyplus Transfection Xpress Biologics, Boster Biological Technology, Trenzyme GmbH
We can customise the report as per your requirements.

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Service Type
4.2. Pre-clinical & Clinical Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Commercial Production Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET: BY HOST CELL 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Host Cell
5.2. Mammalian Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Bacterial Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Insect Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Yeast & Fungi Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET: BY END-USER 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast End-user
6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET: BY REGION 2022-2034(USD MN)

7.1. Regional Outlook
7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Service Type
- 7.2.2 By Host Cell
- 7.2.3 By End-user
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Service Type
- 7.3.2 By Host Cell
- 7.3.3 By End-user
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Service Type
- 7.4.2 By Host Cell
- 7.4.3 By End-user
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Service Type
- 7.5.2 By Host Cell
- 7.5.3 By End-user
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Service Type
- 7.6.2 By Host Cell
- 7.6.3 By End-user
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Recent Developments
8.2. Company Categorization
8.3. Supply Chain & Channel Partners (based on availability)
8.4. Market Share & Positioning Analysis (based on availability)
8.5. Vendor Landscape (based on availability)
8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Company Profiles
- 9.2.1 Lonza Group AG
- 9.2.2 Boehringer Ingelheim International GmbH
- 9.2.3 FUJIFILM Diosynth Biotechnologies
- 9.2.4 Merck KGaA
- 9.2.5 Bruker Corporation (InVivo BioTech Services GmbH)
- 9.2.6 Sino Biological Inc
- 9.2.7 GenScript Biotech Corporation
- 9.2.8 Kaneka Corporation (Kaneka Eurogentec S.A.)
- 9.2.9 Polyplus Transfection (Xpress Biologics)
- 9.2.10 Boster Biological Technology
- 9.2.11 Trenzyme GmbH

02-2729-4219

+886-2-2729-4219

License/价格

全球重组蛋白生产服务市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Recombinant Proteins Manufacturing Services Market Size, Share, Trends & Growth Analysis Report 2026-2034